The Department of Internal Diseases of the Faculty of Medicine together with the Latvian Society of Internal Medicine and the Latvian Association of Haematology are organising an online seminar on the impact of COVID-19 on myocardium and haemostasis on 3 February.
Target audience: lecturers, doctors from various specialties, residents, senior students
Registration is required in order for participants to receive the link to the event.
Programme
The association between COVID-19 and myocarditis
Myocardial damage is one of the most dangerous complications of COVID-19 infection. Even in low symptomatic patients, the risk of late and long-term complications is quite high. A minimal increase in myocarditis in younger patients is noted during vaccination, but this is neither clinically nor statistically significant. The benefits of vaccination are measured by a significant reduction in the number of severe cases.
Cardiologist prof. Oskars Kalējs
COVID-19 vs coagolopathy: pathogenetics and biomarkers based clinical management
Imbalanced immune and hypercoagulation response in the pathogenesis of COVID-19, hypercoagulation vs anticoagulation treatment in COVID-19 associated with thrombosis, thrombotic activity, and septic disseminated intravascular coagulopathy, and arterial thrombosis caused by COVID-19 virus infection.
Clinical haemostasis specialist prof. Julius Ptašekas (Lithuania)*
The seminar will be chaired by Prof. Aivars Lejnieks.
Participants are invited to send their questions in advance by e-mail to aivars[pnkts]lejnieks
rsu[pnkts]lv and they will be forwarded to the lecturers.
